Literature DB >> 7588856

Hepatitis C virus seroconversion in a hemophiliac treated exclusively with solvent/detergent-treated clotting factor concentrate.

S A Evensen, H Rollag, A Glomstein.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7588856     DOI： 10.1007/BF01690743

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN： 0934-9723            Impact factor:   3.267


× No keyword cloud information.
  6 in total

1.  Prevalence of antibodies against hepatitis C virus in Norwegians with congenital coagulation factor defects treated with plasma products from small pools.

Authors:  H Rollag; S A Evesen; S S Fröland; A Glomstein
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-08       Impact factor: 3.267

2.  Frequent patient-to-patient transmission of hepatitis C virus in a haematology ward.

Authors:  T Allander; A Gruber; M Naghavi; A Beyene; T Söderström; M Björkholm; L Grillner; M A Persson
Journal:  Lancet       Date:  1995-03-11       Impact factor: 79.321

3.  Hepatitis C virus infection in children treated for acute lymphoblastic leukemia.

Authors:  M Aricò; G Maggiore; E Silini; F Bono; C Viganò; A Cerino; M U Mondelli
Journal:  Blood       Date:  1994-11-01       Impact factor: 22.113

4.  Prevalence of antibodies to hepatitis C virus among family members of patients with chronic hepatitis C.

Authors:  N Napoli; G Fiore; F Vella; G Fera; O Schiraldi
Journal:  Eur J Epidemiol       Date:  1993-11       Impact factor: 8.082

5.  Confirmation of hepatitis C virus transmission through needlestick accidents by molecular evolutionary analysis.

Authors:  K Suzuki; M Mizokami; J Y Lau; N Mizoguchi; K Kato; Y Mizuno; T Sodeyama; K Kiyosawa; T Gojobori
Journal:  J Infect Dis       Date:  1994-12       Impact factor: 5.226

6.  Identification of genotypes of hepatitis C virus by sequence comparisons in the core, E1 and NS-5 regions.

Authors:  P Simmonds; D B Smith; F McOmish; P L Yap; J Kolberg; M S Urdea; E C Holmes
Journal:  J Gen Virol       Date:  1994-05       Impact factor: 3.891
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.